JG
PRME icon

Jain Global’s Prime Medicine PRME Stock Holding History

Jain Global’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$794K Buy
+215,218
New +$715K ﹤0.01% 1050
2025
Q4 		– Sell
-44,849
Closed -$248K – 1459
2025
Q3 		$248K Buy
+44,849
New +$182K ﹤0.01% 851

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jain Global's PRME Position: Q2 2026 in Review

Jain Global opened a new position in Prime Medicine (PRME) in Q2 2026: 215,218 shares worth $794K. The stake represents ﹤0.01% of the portfolio and ranks #1050 among its holdings. This is a return to the name: Jain Global previously reported a position in PRME as recently as Q3 2025.

Jain Global first reported a position in PRME in Q3 2025 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Jain Global held 215,218 shares of Prime Medicine worth $794K as of Q2 2026.
  • Prime Medicine was a new Jain Global position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1050 holding.
  • Jain Global first reported a position in Prime Medicine in Q3 2025 and has held it in 2 quarters since.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.